Company: MNTR
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001620
Chunk: 1069

Company: Mentor Capital, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 7A
Chunk 1069
---
 been paid by the G Farma
Settlors plus $2,000,000 and all accrued unpaid interest, (2) the Company’s incurred costs, and (3) attorneys’ fees paid
by the Company to obtain the judgment. On July 11, 2023, the Court entered judgment against the G Farma Settlors and in favor of Mentor
and Partner I in the amount of $2,539,597, which is comprised of $2,494,450 in principal (calculated as the aggregate settlement amount,
less payments made by the G Farma Settlors, plus the default addition) plus accrued and unpaid interest of $40,219, costs of $1,643,
and attorneys’ fees of $3,285 incurred by Mentor and Mentor Partner I in connection with obtaining the judgment. The judgment also
accrues post-judgment interest at the rate of 10% from July 11, 2023, until such time as the judgment is paid in full.

    F-38

Mentor
Capital, Inc.

Notes
to Consolidated Financial Statements

December
31, 2024 and 2023

The
Company has retained the full reserve on the unpaid notes receivable balance and collections of the unpaid lease receivable balance due
to the long history of uncertain payments from G Farma and the G Farma Settlors. Payments from the G Farma Settlors will be recognized
in Other Income as they are received. No recovery payments were included in other income in the consolidated financial statements for
the periods ended December 31, 2024 and 2023. The $2,539,597 judgment and interest receivable of $375,025 for the year ended December
31, 2024, is fully reserved pending the outcome of the Company’s collection process. See Notes 1, 8, and 9.

Note
17 – Segment information

Continuing
Operations

The
Company is an operating, acquisition, and investment business. Subsidiaries in which the Company has a controlling financial
interest are consolidated. The Company generally has two reportable
segments: 1) the historic residual operations segment, which formerly included the cost basis of our former membership interests of
Electrum, the former contractual interest in the Electrum legal recovery prior to settlement and payment to the Company on or about
September 14, 2022, the settlement payments receivable from G Farma and its co